$207.09
-7.25-3.38%
At Close: -
$207.09
00.00%
After Hours: 4:05 PM EDT
15 minutes delayed
Comments
Loading...
Labcorp Holdings
LHNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Labcorp Holdings (NYSE:LH) Stock, Analyst Ratings, Price Targets, Forecasts
Labcorp Holdings Inc has a consensus price target of $271.73 based on the ratings of 23 analysts. The high is $380 issued by Morgan Stanley on December 17, 2021. The low is $210 issued by HSBC on September 6, 2023. The 3 most-recent analyst ratings were released by Evercore ISI Group, Baird, and Baird on July 9, 2024, July 8, 2024, and June 13, 2024, respectively. With an average price target of $244.67 between Evercore ISI Group, Baird, and Baird, there's an implied 18.15% upside for Labcorp Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Baird
JP Morgan
Truist Securities
Barclays
1calculated from analyst ratings
Analyst Ratings for Labcorp Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 3.82% | Evercore ISI Group | Elizabeth Anderson | $210 → $215 | Maintains | In-Line | Get Alert |
| 07/08/2024 | Buy Now | 26.03% | Baird | Eric Coldwell | $258 → $261 | Maintains | Outperform | Get Alert |
| 06/13/2024 | Buy Now | 24.58% | Baird | Eric Coldwell | $256 → $258 | Maintains | Outperform | Get Alert |
| 05/30/2024 | Buy Now | 17.34% | JP Morgan | Lisa Gill | $261 → $243 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 23.13% | Truist Securities | Ryan MacDonald | $270 → $255 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 2.85% | Barclays | Stephanie Davis | $234 → $213 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 17.82% | Baird | Eric Coldwell | $255 → $244 | Maintains | Outperform | Get Alert |
| 03/25/2024 | Buy Now | — | Argus Research | David Toung | — | Upgrade | Hold → Buy | Get Alert |
| 02/26/2024 | Buy Now | 25.55% | Leerink Partners | Michael Cherny | → $260 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | Buy Now | 15.89% | Evercore ISI Group | Elizabeth Anderson | → $240 | Initiates | → In-Line | Get Alert |
| 01/03/2024 | Buy Now | 7.2% | Barclays | Stephanie Davis | → $222 | Initiates | → Equal-Weight | Get Alert |
| 11/17/2023 | Buy Now | 26.03% | JP Morgan | John Stansel | $259 → $261 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | 11.06% | Mizuho | Ann Hynes | $257 → $230 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | 11.06% | B of A Securities | Derik De Bruin | $238 → $230 | Maintains | Buy | Get Alert |
| 09/18/2023 | Buy Now | 14.44% | Baird | Eric Coldwell | $251 → $237 | Maintains | Outperform | Get Alert |
| 09/15/2023 | Buy Now | 30.38% | Truist Securities | Ryan MacDonald | → $270 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | 24.1% | Mizuho | Ann Hynes | → $257 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 1.41% | HSBC | Morten Herholdt | → $210 | Initiates | → Hold | Get Alert |
| 08/14/2023 | Buy Now | 30.38% | Wells Fargo | Timothy Daley | $290 → $270 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | 25.55% | Morgan Stanley | Ricky Goldwasser | $285 → $260 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 11.55% | Credit Suisse | Jonathan Yong | $247.41 → $231 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 21.2% | Baird | Eric Coldwell | $255 → $251 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | 30.38% | Truist Securities | Ryan MacDonald | $275 → $270 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 39.07% | Credit Suisse | Jonathan Yong | → $288 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | Buy Now | 24.1% | Mizuho | Ann Hynes | $277 → $257 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 37.62% | Morgan Stanley | Ricky Goldwasser | $295 → $285 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | 32.79% | Truist Securities | Ryan MacDonald | $285 → $275 | Maintains | Buy | Get Alert |
| 03/13/2023 | Buy Now | 39.07% | Credit Suisse | Jonathan Yong | $304 → $288 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 46.8% | Credit Suisse | Jonathan Yong | $305 → $304 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 40.04% | Wells Fargo | Timothy Daley | $315 → $290 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | 37.62% | Truist Securities | David Macdonald | $275 → $285 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | 25.55% | Citigroup | Patrick Donnelly | $250 → $260 | Maintains | Neutral | Get Alert |
| 02/17/2023 | Buy Now | 44.86% | Baird | Eric Coldwell | $285 → $300 | Maintains | Outperform | Get Alert |
| 02/17/2023 | Buy Now | 33.76% | Mizuho | Ann Hynes | $250 → $277 | Maintains | Buy | Get Alert |
| 01/11/2023 | Buy Now | 37.62% | Baird | Eric Coldwell | $270 → $285 | Maintains | Outperform | Get Alert |
| 01/06/2023 | Buy Now | 46.31% | Morgan Stanley | Ricky Goldwasser | $290 → $303 | Maintains | Overweight | Get Alert |
| 12/12/2022 | Buy Now | 20.72% | Citigroup | Patrick Donnelly | → $250 | Downgrade | Buy → Neutral | Get Alert |
| 11/23/2022 | Buy Now | 47.28% | Credit Suisse | A.J. Rice | $308 → $305 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 20.72% | Mizuho | Ann Hynes | $296 → $250 | Maintains | Buy | Get Alert |
| 10/31/2022 | Buy Now | 40.04% | Morgan Stanley | Ricky Goldwasser | $300 → $290 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 25.55% | Truist Securities | David Macdonald | $275 → $260 | Maintains | Buy | Get Alert |
| 08/22/2022 | Buy Now | 44.86% | Morgan Stanley | Erin Wright | → $300 | Assumes | → Overweight | Get Alert |
| 08/01/2022 | Buy Now | 48.73% | Credit Suisse | A.J. Rice | $312 → $308 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | 42.93% | Mizuho | Ann Hynes | $323 → $296 | Maintains | Buy | Get Alert |
| 05/25/2022 | Buy Now | 44.86% | Morgan Stanley | Ricky Goldwasser | $360 → $300 | Maintains | Overweight | Get Alert |
| 05/03/2022 | Buy Now | 27.96% | Deutsche Bank | Pito Chickering | $294 → $265 | Maintains | Hold | Get Alert |
| 05/02/2022 | Buy Now | 50.66% | Credit Suisse | A.J. Rice | $344 → $312 | Maintains | Outperform | Get Alert |
| 04/25/2022 | Buy Now | 52.11% | Wells Fargo | Timothy Daley | $320 → $315 | Maintains | Overweight | Get Alert |
| 02/14/2022 | Buy Now | 73.84% | Morgan Stanley | Ricky Goldwasser | $380 → $360 | Maintains | Overweight | Get Alert |
| 02/11/2022 | Buy Now | 66.11% | Credit Suisse | Jonathan Yong | $340 → $344 | Maintains | Outperform | Get Alert |
| 01/28/2022 | Buy Now | 41.97% | Deutsche Bank | Pito Chickering | → $294 | Downgrade | Buy → Hold | Get Alert |
| 12/20/2021 | Buy Now | 70.94% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
| 12/17/2021 | Buy Now | 83.5% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 12/14/2021 | Buy Now | 64.18% | Wells Fargo | Dan Leonard | — | Maintains | Overweight | Get Alert |
| 11/01/2021 | Buy Now | 63.21% | Credit Suisse | Jonathan Yong | — | Maintains | Outperform | Get Alert |
| 10/29/2021 | Buy Now | 82.05% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
| 08/31/2021 | Buy Now | 77.7% | Morgan Stanley | Craig Hettenbach | — | Maintains | Overweight | Get Alert |
| 08/20/2021 | Buy Now | 62.25% | Credit Suisse | — | — | Maintains | Outperform | Get Alert |
| 08/19/2021 | Buy Now | 60.32% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
| 07/30/2021 | Buy Now | 59.35% | Deutsche Bank | Pito Chickering | — | Maintains | Buy | Get Alert |
| 07/30/2021 | Buy Now | 53.56% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Labcorp Holdings (LH) stock?
The latest price target for Labcorp Holdings (NYSE:LH) was reported by Evercore ISI Group on July 9, 2024. The analyst firm set a price target for $215.00 expecting LH to rise to within 12 months (a possible 3.82% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Labcorp Holdings (LH)?
The latest analyst rating for Labcorp Holdings (NYSE:LH) was provided by Evercore ISI Group, and Labcorp Holdings maintained their in-line rating.
When was the last upgrade for Labcorp Holdings (LH)?
The last upgrade for Labcorp Holdings Inc happened on March 25, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Labcorp Holdings Inc.
When was the last downgrade for Labcorp Holdings (LH)?
The last downgrade for Labcorp Holdings Inc happened on December 12, 2022 when Citigroup changed their price target from N/A to $250 for Labcorp Holdings Inc.
When is the next analyst rating going to be posted or updated for Labcorp Holdings (LH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Labcorp Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Labcorp Holdings was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating Labcorp Holdings (LH) correct?
While ratings are subjective and will change, the latest Labcorp Holdings (LH) rating was a maintained with a price target of $210.00 to $215.00. The current price Labcorp Holdings (LH) is trading at is $207.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.